Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases
byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
Updated on: January 02,2024
9

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases
byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
Updated on:January 02,2024
9
